VAXNEUVANCE 30 ug/.5mL (Pneumococcal 15-valent Conjugate Vaccine CRM197 Protein adsorbed INJECTION, SUSPENSION) 30 ug/.5mL

VAXNEUVANCE 30 ug/0.5mL is a pneumococcal 15-valent conjugate vaccine designed for intramuscular administration. It helps protect against pneumococcal diseases caused by 15 serotypes. This vaccine is suitable for individuals at risk of pneumococcal infections.

Strength

30 ug/.5mL

Pack Size

1 SYRINGE, GLASS in 1 CARTON (0006-4329-02) / .5 mL in 1 SYRINGE, GLASS (0006-4329-01)

Manufacturer / TM Owner

Merck Sharp & Dohme LLC

Select Quantity

Pack/s

Request a Quote

Please fill out the form below and our team will get back to you shortly with pricing and further information.

First Name

Last Name

Phone

Delivery Country

Delivery PostCode/Zipcode

Select Your Profile

I have read and agree to the terms & conditions, including the privacy policy, return policy, and usage terms as applicable to this request.

Indications & Clinical Uses

VAXNEUVANCE 30 ug/0.5mL is used to prevent pneumococcal diseases, including pneumonia, bacteremia, and meningitis. It is particularly important for individuals who are at higher risk of pneumococcal infections, such as those with weakened immune systems or chronic health conditions. The vaccine works by stimulating the body's immune response to protect against specific serotypes of the pneumococcus bacteria.

Side Effects

Common effects of VAXNEUVANCE 30 ug/0.5mL may include mild to moderate reactions at the injection site, such as redness, swelling, and pain. Some individuals may also experience temporary systemic effects like fatigue, headache, or muscle pain. These effects are generally short-lived and resolve on their own.

Precautions & Warnings

VAXNEUVANCE 30 ug/0.5mL should be administered by healthcare professionals trained in intramuscular injections. It is important to inform your healthcare provider about any allergies or medical conditions before receiving the vaccine. Individuals with a history of severe allergic reactions to any component of the vaccine should avoid it.

Avoid Interactions

VAXNEUVANCE 30 ug/0.5mL may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with your healthcare provider to avoid potential interactions. Alcohol and other immune-suppressing substances may affect the vaccine's effectiveness.

Frequently Asked Questions

VAXNEUVANCE 30 ug/0.5mL is used to prevent pneumococcal diseases caused by 15 serotypes, including pneumonia, bacteremia, and meningitis.

VAXNEUVANCE 30 ug/0.5mL is administered as an intramuscular injection by a healthcare professional.

Common effects may include mild to moderate reactions at the injection site, such as redness, swelling, and pain, as well as temporary systemic effects like fatigue, headache, or muscle pain.

Individuals with a history of severe allergic reactions to any component of the vaccine should avoid VAXNEUVANCE 30 ug/0.5mL.

VAXNEUVANCE 30 ug/0.5mL may interact with certain medications or other vaccines. It is advisable to discuss your current medications and vaccination schedule with your healthcare provider.

Editorial & Trust Signals

Published by

GNH India Pharmaceuticals Limited

Licensed pharmaceutical wholesaler & exporter

Last updated: 17 Jun 2026

References

Disclaimer

At GNH India, we aim to provide information that is expert-reviewed, accurate, and reliable. However, all content on this platform is intended for general informational purposes only and does not constitute professional medical advice, diagnosis, or treatment. While efforts are made to maintain accuracy and currency, the information may contain errors, omissions, or may not reflect the latest developments. Always consult a qualified healthcare professional regarding any medical concerns.

All product names, brand names, trademarks and registered trademarks displayed on this website are the property of their respective owners. This website and its operator are not affiliated with, endorsed by, or authorized by any such trade mark owners unless expressly stated. Any reference to product names or trademarks is made solely for descriptive and informational purposes. No commercial relationship, sponsorship, approval, or association with any trademark owner should be inferred. Information provided herein does not constitute promotion, advertising, or an offer for sale of any medicinal product and is intended solely for general informational purposes.

All trademarks and brand names displayed on this website are used strictly in accordance with the provisions of the Trade Marks Act, 1999, specifically Sections 30 and 30(1) governing fair use. Trademark ownership has been accurately attributed under the "Manufacturer/ TM Owner" section in compliance with statutory requirements.